JPS6384497A - Production of tropan based alkaloid - Google Patents
Production of tropan based alkaloidInfo
- Publication number
- JPS6384497A JPS6384497A JP61230155A JP23015586A JPS6384497A JP S6384497 A JPS6384497 A JP S6384497A JP 61230155 A JP61230155 A JP 61230155A JP 23015586 A JP23015586 A JP 23015586A JP S6384497 A JPS6384497 A JP S6384497A
- Authority
- JP
- Japan
- Prior art keywords
- medium
- plant
- present
- tropan
- amines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 229930013930 alkaloid Natural products 0.000 title abstract description 19
- 150000003797 alkaloid derivatives Chemical class 0.000 title abstract description 10
- 150000001412 amines Chemical class 0.000 claims abstract description 18
- 229930004668 tropane alkaloid Natural products 0.000 claims description 18
- 150000003813 tropane derivatives Chemical class 0.000 claims description 15
- 238000012258 culturing Methods 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 abstract description 26
- 239000001963 growth medium Substances 0.000 abstract description 10
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 abstract description 10
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 abstract description 8
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 abstract description 8
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 abstract description 8
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 abstract description 8
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 abstract description 8
- 229960002646 scopolamine Drugs 0.000 abstract description 8
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 abstract description 7
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 abstract description 7
- 229930005342 hyoscyamine Natural products 0.000 abstract description 7
- 229960003210 hyoscyamine Drugs 0.000 abstract description 7
- 239000003375 plant hormone Substances 0.000 abstract description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 5
- 229910052799 carbon Inorganic materials 0.000 abstract description 5
- 229940063673 spermidine Drugs 0.000 abstract description 5
- 229940088594 vitamin Drugs 0.000 abstract description 5
- 229930003231 vitamin Natural products 0.000 abstract description 5
- 235000013343 vitamin Nutrition 0.000 abstract description 5
- 239000011782 vitamin Substances 0.000 abstract description 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract description 4
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 abstract description 4
- 241000208296 Datura Species 0.000 abstract description 3
- 241000208278 Hyoscyamus Species 0.000 abstract description 3
- 239000005700 Putrescine Substances 0.000 abstract description 3
- 241001469188 Duboisia Species 0.000 abstract description 2
- 229960001340 histamine Drugs 0.000 abstract description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 abstract description 2
- 229940063675 spermine Drugs 0.000 abstract description 2
- 241000242873 Scopolia Species 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 45
- 210000004027 cell Anatomy 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- XLRPYZSEQKXZAA-OCAPTIKFSA-N tropane Chemical compound C1CC[C@H]2CC[C@@H]1N2C XLRPYZSEQKXZAA-OCAPTIKFSA-N 0.000 description 9
- 229930004006 tropane Natural products 0.000 description 9
- 239000007788 liquid Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 206010020649 Hyperkeratosis Diseases 0.000 description 6
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 6
- -1 ammonium ions Chemical class 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 210000004748 cultured cell Anatomy 0.000 description 4
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- STECJAGHUSJQJN-USLFZFAMSA-N LSM-4015 Chemical compound C1([C@@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-USLFZFAMSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 3
- 239000004062 cytokinin Substances 0.000 description 3
- 239000003617 indole-3-acetic acid Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001106067 Atropa Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241001469190 Duboisia myoporoides Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- JKQOBWVOAYFWKG-UHFFFAOYSA-N molybdenum trioxide Chemical compound O=[Mo](=O)=O JKQOBWVOAYFWKG-UHFFFAOYSA-N 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N n-pentylamine Natural products CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- 210000005037 parasympathetic nerve Anatomy 0.000 description 2
- 238000004161 plant tissue culture Methods 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- ZNZJJSYHZBXQSM-UHFFFAOYSA-N propane-2,2-diamine Chemical compound CC(C)(N)N ZNZJJSYHZBXQSM-UHFFFAOYSA-N 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 2
- DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- HABAPWZXRLIZDL-UHFFFAOYSA-N 2-chloro-2-phenoxyacetic acid Chemical compound OC(=O)C(Cl)OC1=CC=CC=C1 HABAPWZXRLIZDL-UHFFFAOYSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 240000008853 Datura stramonium Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000122904 Mucuna Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000206609 Porphyra Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 1
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 1
- 229960003732 tyramine Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940023877 zeatin Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はズボイシア、ダツラ、ハシリドコロ、ヒヨス等
のトロパン系アルカロイドヲ代謝産生ずる植物の組織を
特定の培地を用いて組織培養することによりスコポラミ
ンおよび/又はヒヨスチアミン等のトロパン系アルカロ
イドを製造する方法に関する。[Detailed Description of the Invention] [Field of Industrial Application] The present invention produces scopolamine and The present invention relates to a method for producing a tropane alkaloid such as hyoscyamine.
スコポラミンは鎮痙剤、鎮痛剤および副交感神経しゃ断
薬として、またヒヨスチアミンは副交感神経しゃ断薬と
して、それぞれ医薬として重用されている。これらの化
合物は、天然の植物対中から抽出して製造されているが
、天然物を原料としているため、その生産が天候に左右
されること、収穫時期が限定されていることなどが問題
となっている。そのためこれらの化合物を植物の組織培
養により生産する研究が内外で数多く行われた。カルス
による生産では、山田らによるヒヨスのカルスによる生
産例が知られている(PlantCell Repor
ts上、101〜103(1982) )が、スコポラ
ミン含量は20ppmと、天然の植物体中の含量と比較
して低いものであった。また山田らは、ズボイシア(D
uboisia Leichhardtii F、 M
uell)の組織培養により得られる不定根中に著量の
スコポラミンおよびヒヨスチアミンが存在することを見
出している(Plant Ce1l Reports
3.186−188(1984) )が、その量はま
た充分とは言えないものであった。そこで1、ズボイシ
ア不定根の各種培養条件を検討し、培地のアンモニウム
イオンと硝酸イオンの比率を0.2以上にすることおよ
び培地の溶存酸素濃度を10ないし65ppmとするこ
とにより、トロパン系アルカロイドの生産性を向上させ
ることを見出し、本出願人はそれぞれ特願昭60−14
3882号および特願昭6’0−143881号として
特許出願をしているが、工業的な見地からはその生産性
を更に高めることが望まれる。Scopolamine is used as an antispasmodic, analgesic, and parasympathetic nerve blocker, and hyoscyamine is used as a parasympathetic nerve blocker, each of which is used as a medicine. These compounds are manufactured by extracting them from natural plants, but because they are made from natural materials, there are problems such as production being affected by the weather and the harvesting period being limited. It has become. Therefore, many studies have been conducted both domestically and internationally to produce these compounds through plant tissue culture. Regarding production by callus, there is a known example of production by Yamada et al. using henbane callus (PlantCell Report
TS, 101-103 (1982)), the scopolamine content was 20 ppm, which was lower than the content in natural plants. Furthermore, Yamada et al.
uboisia Leichhardtii F, M
It has been found that significant amounts of scopolamine and hyoscyamine are present in adventitious roots obtained by tissue culture of Plant Cell (Plant Cell Reports).
3.186-188 (1984)), but the amount was still not sufficient. Therefore, 1. We investigated various culture conditions for Zboisia adventitious roots, and by setting the ratio of ammonium ions to nitrate ions in the medium to 0.2 or more and the dissolved oxygen concentration in the medium to 10 to 65 ppm, we were able to produce tropane-based alkaloids. The present applicant has each filed a patent application in 1986-14.
Although patent applications have been filed as No. 3882 and Japanese Patent Application No. 6'0-143881, it is desired to further increase the productivity from an industrial standpoint.
したがってこのような組織培養によりトロパン系アルカ
ロイドの工業的な生産を目指す場合、さらに生産性を高
めることが重要な課題であった。Therefore, when aiming at industrial production of tropane-based alkaloids using such tissue culture, it has been an important issue to further increase productivity.
このような事情にかんがみ、本発明者らは、ズボイシア
、ダツラ、ハシリドコロおよびヒヨス属等のトロパン系
アルカロイドを産生ずる植物の不定根等の組織、細胞を
効率よく培養する方法を研究した結果、次のような事実
を見出した。In view of these circumstances, the present inventors have researched methods for efficiently cultivating tissues and cells such as adventitious roots of plants that produce tropane alkaloids, such as Zboisia, Datura, Porphyra, and Hyosus, and have found the following. I found such a fact.
〔問題点を解決するための手段〕
従来の組織培養方法においてはカルス、不定根等の細胞
、組織を培養する場合、培地にはアミンに属する化合物
は添加されていない。そこで、本発明者等はこの成分を
培地に添加して培養を試みた所、トロパン系アルカロイ
ドを産生ずる植物の組織から培養によって得られる不定
根等の培養された組織、細胞のトロパン系アルカロイド
含量が向上するか、あるいは不定根等の¥&織、細胞の
成育が促進され、結果としてトロパン系アルカロイドの
生産性が向上することを見出し、本発明を完成するに到
った。[Means for Solving the Problems] In conventional tissue culture methods, when culturing cells and tissues such as callus and adventitious roots, compounds belonging to amines are not added to the medium. Therefore, the present inventors added this component to the culture medium and tried culturing, and found that the tropane alkaloid content of cultured tissues such as adventitious roots and cells obtained by culture from the tissues of plants that produce tropane alkaloids. The present invention has been completed based on the discovery that the productivity of tropane-based alkaloids is improved by promoting the growth of cells such as adventitious roots, and as a result, the productivity of tropane-based alkaloids is improved.
すなわち、本発明の方法によれば、トロパン系アルカロ
イドを産生ずる植物の組織をアミン類を含有する培地を
用いて組織培養してトロパン系アルカロイドを生産する
ことを特徴とするトロパン系アルカロイドの生産方法が
提供される。That is, according to the method of the present invention, a method for producing tropane alkaloids, which comprises culturing tissues of plants that produce tropane alkaloids using a medium containing amines to produce tropane alkaloids. is provided.
本発明では組織培養はトロパン系アルカロイドを産生ず
る植物を用いて行われるが、該当する植物として具体的
には、Duboisia myoporoides+D
uboisia 1eichhardtii等のズボイ
シア属植物、Datura tatula+ Datu
ra arboea、 Daturastramoni
um等のダツラ属植物、5copolia japon
ica等のスコボリア属植物、Hyoscyamus
niger等のヒヨス属植物およびAtropa be
lladonna等のアトローパ属植物などのナス科植
物を例示することができる。In the present invention, tissue culture is carried out using plants that produce tropane-based alkaloids, and specifically, Duboisia myoporoides+D
Plants of the genus Zboisia such as Uboisia 1eichhardtii, Datura tatula+ Datu
ra arboea, Daturastramoni
Plants of the genus Datura such as um, 5copolia japon
Scoboria plants such as ica, Hyoscyamus
plants of the genus Mucuna such as niger and Atropa be
Examples include plants of the family Solanaceae, such as plants of the genus Atropa such as lladonna.
本発明では前記植物の組織を培養してトロパン系アルカ
ロイドを生産するに当たって、アミン類を含有する培地
が用いられる。以下これについて詳述する。In the present invention, a medium containing amines is used to produce tropane alkaloids by culturing the plant tissues. This will be explained in detail below.
本発明で使用される培地はアミン類を含有する培地であ
って、該成分以外の他の成分として無機成分および炭素
源を必須成分とし、これに植物ホルモン類、ビタミン類
を添加し、更に必要に応じてアミノ酸類を添加した培地
である。The medium used in the present invention is a medium containing amines, and has inorganic components and carbon sources as essential components other than these components, and plant hormones and vitamins are added thereto. This is a medium to which amino acids are added according to the conditions.
本発明に係わるアミン類とは以下に示すアミン類をさす
。すなわち、本発明で使用することのできるアミン類と
は、スペルミン
CHJ−(C1l□)3N11− (CHz) *−N
H−(C)Iz) 3−NH2) 、スペルミジン(H
zN−(CHz) JH−(CHz) 4−NH2)
、プトレシン(HgN−(CL) t−NHz)などの
テトラメチレンジアミンとその誘導体およびジアミノプ
ロパンCHtN−(CHz) *−NHz)などのポリ
アルキレンポリアミン類及びアミノプロパン、アミツブ
クン、アミノペンタン等の低級アルキルモノアミン類お
よびチラミン、トリプタミン、ヒスタミン等の低級アル
キルモノアミ°ン類の末端位がヒドロキシフェニル基、
インドール残基又はイミダゾール残基で置換されている
置換低級アルキルモノアミン類である。The amines according to the present invention refer to the following amines. That is, the amines that can be used in the present invention include spermine CHJ-(C1l□)3N11- (CHz) *-N
H-(C)Iz) 3-NH2), spermidine (H
zN-(CHz) JH-(CHz) 4-NH2)
, tetramethylene diamine and its derivatives such as putrescine (HgN-(CL) t-NHz), polyalkylene polyamines such as diaminopropane CHtN-(CHtN-(CHz) *-NHz), and lower alkyls such as aminopropane, amitubukun, aminopentane, etc. The terminal position of monoamines and lower alkyl monoamines such as tyramine, tryptamine, and histamine is a hydroxyphenyl group,
Substituted lower alkyl monoamines substituted with indole or imidazole residues.
本発明では該アミン類の使用割合としては、培地におけ
るアミン類の濃度が通常0.01mMないし10mM、
好ましくは0.1mMないし5mMの濃度になるように
して使用される。本発明では前記アミン類を1種又は2
種以上混合使用しても差し支えない。In the present invention, the usage ratio of the amines is such that the concentration of the amines in the medium is usually 0.01mM to 10mM;
It is preferably used at a concentration of 0.1mM to 5mM. In the present invention, one or two of the above amines are used.
It is okay to use a mixture of more than one species.
本発明方法のようにアミン類を含む培地を用いて前記植
物の組織を培養した場合にはアミン類を含まない培地を
使用した場合に比べてトロパン系アルカロイドの生産量
が増大する。When the plant tissue is cultured using a medium containing amines as in the method of the present invention, the production amount of tropane alkaloids is increased compared to when a medium containing no amines is used.
本発明で使用される培地において、前記したアミン類以
外の他の培地成分については、無機成分としては、窒素
、リン、カリウム、ナトリウム、カルシウム、マグネシ
ウム、イオウ、鉄、マンガン、亜鉛、ホウ素、モリブデ
ン、塩素、ヨウ素、コバルト等の元素を含む無機塩を挙
げることができ、具体的には硝酸カリウム、硝酸ナトリ
ウム、硝酸アンモニウム、塩化アンモニウム、塩化カリ
ウム、塩化カルシウム、リン酸1水素カリウム、リン酸
2水素カリウム、硫酸マグネシウム、塩化マグネシウム
、硫酸ナトリウム、硫酸第1鉄、硫酸第2鉄、硫酸マン
ガン、硫酸銅、モリブデン酸ナトリウム、三酸化モリブ
デン、ヨウ化カリウム、硫酸亜鉛、ホウ酸、塩化コバル
ト等の化合物を例示できる。In the culture medium used in the present invention, inorganic components other than the above-mentioned amines include nitrogen, phosphorus, potassium, sodium, calcium, magnesium, sulfur, iron, manganese, zinc, boron, and molybdenum. Examples include inorganic salts containing elements such as , chlorine, iodine, and cobalt; specific examples include potassium nitrate, sodium nitrate, ammonium nitrate, ammonium chloride, potassium chloride, calcium chloride, potassium monohydrogen phosphate, and potassium dihydrogen phosphate. , magnesium sulfate, magnesium chloride, sodium sulfate, ferrous sulfate, ferric sulfate, manganese sulfate, copper sulfate, sodium molybdate, molybdenum trioxide, potassium iodide, zinc sulfate, boric acid, cobalt chloride, etc. I can give an example.
該培地の炭素源としては、ショ糖等の炭水化物とその誘
導体、脂肪酸等の有機酸およびエタノール等の1級アル
コールなどを例示できる。Examples of carbon sources for the medium include carbohydrates such as sucrose and derivatives thereof, organic acids such as fatty acids, and primary alcohols such as ethanol.
該培地の植物ホルモン類としては、例えば、ナフタレン
酢酸(NAA) 、インドール酢酸(IAA) 、p−
クロロフェノキシ酢酸、2.4−ジクロロフェノキシ酢
酸(2,4−D)、インドール酪酸(IBM)およびこ
れらの誘導体等のオーキシン類およびベンジルアデニン
(BA)、カイネチン、ゼアチン等のサイトカイニン類
を例示できる。本発明ではサイトカイニン類は通常は培
地に添加しないことが望ましいが、必要に応じて添加す
る場合にはサイトカイニン類は濃度が通常10−?M(
0,02mg/ 1 )以下の低濃度で使用することが
好ましい。Examples of plant hormones in the medium include naphthalene acetic acid (NAA), indole acetic acid (IAA), p-
Examples include auxins such as chlorophenoxyacetic acid, 2,4-dichlorophenoxyacetic acid (2,4-D), indolebutyric acid (IBM), and derivatives thereof, and cytokinins such as benzyladenine (BA), kinetin, and zeatin. In the present invention, it is usually preferable not to add cytokinins to the culture medium, but when they are added as necessary, the concentration of cytokinins is usually 10-? M(
It is preferable to use it at a low concentration of 0.02 mg/1) or less.
該培地のビタミン類としては、ビオチン、チアミン(ビ
タミンB、) 、ピリドキシン(ビタミンBl、)、ピ
リドキサール、ピリドキサミン、パントテン酸カルシウ
ム、アスコルビン酸(ビタミンC)、イノシトール、ニ
コチン酸、ニコチン酸アミドおよびリボブラビン(ビタ
ミンth)などを例示できる。The vitamins in the medium include biotin, thiamine (vitamin B), pyridoxine (vitamin Bl), pyridoxal, pyridoxamine, calcium pantothenate, ascorbic acid (vitamin C), inositol, nicotinic acid, nicotinamide, and ribobravin (vitamin C). Examples include vitamin th).
該培地のアミノ酸類としては、例えばグリシン、アラニ
ン、グルタミン酸、システィン、フェニルアラニンおよ
びリジンなどを例示できる。Examples of amino acids in the medium include glycine, alanine, glutamic acid, cysteine, phenylalanine, and lysine.
本発明の前記培地は、通常は、前記無機成分を約0.1
μMないし約100mM、前記炭素源を約1g/lない
し約100 g / It、前記植物ホルモン類を約0
.01μMないし約100μM1前記ビタミン類を約0
.lIIIg / Itないし約150mg/ lおよ
び前記アミノ類類をOないし約1000mg/ Il含
ませて使用されることが望ましい。The medium of the present invention usually contains about 0.1 of the inorganic components.
μM to about 100 mM, about 1 g/l to about 100 g/It of the carbon source, about 0 g/It of the plant hormones.
.. 01 μM to about 100 μM1 The above vitamins are added to about 0
.. It is preferable to use lIIIg/It to about 150 mg/L and the above aminos in O to about 1000 mg/Il.
本発明のズボイシア属植物の組織培養に用いられる前記
培地として具体的には、従来から知られている植物の組
織培養に用いられている培地、例えば、ムラシゲ・スク
ーグ(’62) (Murashige &Skoo
g )の培地、リンスマイヤー・スクーグ(RM−19
65) CLinsmaier & Skoog )
の培地、ホワイト(’63) (White )の培
地、ガンボルグ(Gamborg )の8−5培地、三
井の19培地、ニッチ・ニッチ(Nitsch N1t
sch )の培地等に前記した炭素源および植物ホルモ
ンを添加し、更に必要に応じて前記したビタミン類、ア
ミノ酸類を添加して調製される培地を例示できるが、本
発明ではこの中でも特にエッチ・エッチ、リンスマイヤ
ー・スクーグ又はムラシゲ・スクーグの培地を用いて調
製される培地が好ましい。なお、上記した従来公知の培
地の組成に関しては、例えば、行内、中隔、古谷著の「
新植物組織培養J P386〜P391、朝倉書店、1
979年に記載されている。Specifically, the medium used for the tissue culture of plants belonging to the genus Zboisia of the present invention includes a conventionally known culture medium used for tissue culture of plants, such as Murashige & Skoo ('62).
g) medium, Linsmeyer-Skoog (RM-19
65) Clinsmaier & Skoog)
medium, White medium, Gamborg 8-5 medium, Mitsui 19 medium, Nitsch N1t medium.
An example is a culture medium prepared by adding the above-mentioned carbon source and plant hormone to a culture medium of sch. Preferably, the medium is prepared using Hetch, Linsmeyer-Skoog or Murashige-Skoog medium. Regarding the composition of the above-mentioned conventionally known culture medium, for example, "
New Plant Tissue Culture JP P386-P391, Asakura Shoten, 1
It was written in 979.
本発明で使用できる前記培地は液体培地又は寒天やゼラ
チン等を通常0.5〜1%含有させた固型培地であるが
本発明では液体培地を用いることが好ましい。The medium that can be used in the present invention is a liquid medium or a solid medium containing usually 0.5 to 1% of agar, gelatin, etc., but it is preferable to use a liquid medium in the present invention.
本発明の組織培養ではトロパン系アルカロイドを代謝産
生ずる植物の組織片は、前記培地を用いて組織培養され
てトロパン系アルカロイドを含有する培養細胞ないし培
養組織が得られる。In the tissue culture of the present invention, tissue pieces of plants that metabolize tropane alkaloids are tissue cultured using the above medium to obtain cultured cells or cultured tissues containing tropane alkaloids.
本発明では該培養組織としては不定根が特に好ましい。In the present invention, adventitious roots are particularly preferred as the cultured tissue.
本発明の組織培養に用いられる前記植物の組織として具
体的には、該植物の根、葉、茎、種子、花芽などの他に
も本発明に係わる組織培養あるいは他の従来の組織培養
方法によって得られる該植物の培養細胞ないし培養組織
を例示できる。本発明では、これらの中では植物組織を
前もって組織培養して得られる不定根を使用してこれを
本発明に係わる培地を用いて組織培養することが特に好
ましく、この場合には原料の不定根が本発明の培地を用
いて増殖培養されてトロパン系アルカロイドを多量含有
する不定根が得られる。Specifically, the tissues of the plants used in the tissue culture of the present invention include roots, leaves, stems, seeds, flower buds, etc. of the plants, as well as those that can be used in the tissue culture of the present invention or other conventional tissue culture methods. The resulting cultured cells or tissue of the plant can be exemplified. In the present invention, among these, it is particularly preferable to use adventitious roots obtained by previously tissue culturing plant tissues and tissue culture them using the medium according to the present invention. In this case, the adventitious roots as raw materials are Adventitious roots containing a large amount of tropane alkaloids can be obtained by propagation and culture using the medium of the invention.
本発明では通常前記した組織片あるいは細胞からカルス
が誘導され、該カルスを継代培養して得られる培養細胞
ないしは培養組織は本発明の前記培地を用いて増殖培養
されてトロパン系アルカロイドを多量含有する培養物、
特に不定根を得るというような組織培養の方法を用いる
ことが好ましい。In the present invention, callus is usually induced from the above-mentioned tissue pieces or cells, and the cultured cells or cultured tissues obtained by subculturing the callus are grown and cultured using the above-mentioned medium of the present invention, and contain a large amount of tropane-based alkaloids. culture,
In particular, it is preferable to use a tissue culture method to obtain adventitious roots.
本発明では不定根を用いる場合に、植物の組織片を例え
ば毛根病菌(例えばAgrobacteriumrh
izogenes)で感染させ、これによって出現する
毛根を用いることもできる(例えば本出願人に係わる特
願昭61−89975号で提案した方法を用いることも
できる)。In the present invention, when using adventitious roots, plant tissue pieces are, for example, hairy root disease bacteria (e.g. Agrobacterium rh).
izogenes) and the resulting hair roots that appear can also be used (for example, the method proposed in Japanese Patent Application No. 61-89975 filed by the present applicant can also be used).
本発明の方法によって得られるトロパン系アルカロイド
として具体的には、スコポラミン、ヒヨスチアミン及び
これらの化合物のアセチル化合物を例示できるが、この
中ではスコポラミンとヒヨスチアミンが好ましい。Specific examples of the tropane alkaloid obtained by the method of the present invention include scopolamine, hyoscyamine, and acetyl compounds of these compounds, and among these, scopolamine and hyoscyamine are preferred.
本発明ではトロパン系アルカロイドを含有する培養細胞
から該アルカロイドを分離する方法としては、例えば薬
局法等に記載されている、トロパン系アルカロイドを含
有する植物からこれら化合物を単離精製する場合に用い
られてきた通常の方法を採用することができる。In the present invention, the method for separating tropane-based alkaloids from cultured cells containing them is, for example, the method used to isolate and purify tropane-based alkaloids from plants containing tropane-based alkaloids, as described in the Pharmacopoeia Act. The usual methods that have been used can be adopted.
本発明の組織培養によるトロパン系アルカロイドの生産
方法を採用すれば、従来法に比べてトロパン系アルカロ
イドを、中でも特にスコポラミンおよび/又はヒヨスチ
アミンを大量に効率よく生産することができる。By employing the method for producing tropane alkaloids by tissue culture of the present invention, tropane alkaloids, especially scopolamine and/or hyoscyamine, can be produced efficiently in large quantities compared to conventional methods.
以下、本発明の方法を実施例によって更に具体的に説明
する。Hereinafter, the method of the present invention will be explained in more detail with reference to Examples.
実施例1
当社薬草園にて栽培したDuboisia mypor
oidesR,Brの葉を洗浄し、10%アンチホルミ
ン液に10分間浸漬し、次いで滅菌水で3回洗浄した後
、約11に切断し、ナフタレン酢酸およびベンジルアデ
ニンをそれぞれ10− ’Mおよび10−’Mとなるよ
うに添加したリンスマイヤー・スクーグの寒天培地に置
床し、25℃で30日間培養する。カルス形成と同時に
発生した不定根を切り出し、インドール醋酸を10−
’Hになるように添加したエッチ・エッチの液体培地に
移植し、2年間継代培養した。このようにして得た不定
根10mg (乾燥重量)をスペルミジンを1mMにな
るように添加し、インドール酪酸を10−’Mになるよ
うに添加したニッチ・ニッチの液体培地20−を含む1
00rn!容の三角フラスコに移植し、3週間振とう培
養した。得られた不定根190mg(乾燥重量)を乾燥
後、塩基性のクロロホルム−メタノール液50m!で抽
出した。これに40mfのIN硫酸を加えてアルカロイ
ド層を硫酸層に移した。さらに、アンモニア水2−およ
びクロロホルム40−を加えてアルカロイドをクロロホ
ルム層に移し、これを減圧濃縮し、ガスクロマトグラフ
でアルカロイド量を分析した。この場合のアルカロイド
の生産量を表1に示した。なお、ガスクロマトグラフの
分析は以下の条件で行った。Example 1 Duboisia mypor grown in our herb garden
oidesR,Br leaves were washed, immersed in 10% antiformin solution for 10 min, then washed 3 times with sterile water, then cut into approximately 11 pieces and treated with naphthaleneacetic acid and benzyladenine at 10-'M and 10-'M, respectively. The cells were plated on a Linsmeyer-Skoog agar medium supplemented with M and cultured at 25°C for 30 days. Adventitious roots that appeared at the same time as callus formation were cut out, and indole acetic acid was added to
The cells were transplanted into an H-H liquid medium supplemented with a concentration of 'H' and subcultured for 2 years. 10 mg (dry weight) of the adventitious roots thus obtained were placed in a 20-ml Niche Niche liquid medium containing 1 mM spermidine and 10 M indolebutyric acid.
00rn! The cells were transplanted into a large Erlenmeyer flask and cultured with shaking for 3 weeks. After drying 190 mg (dry weight) of the obtained adventitious roots, 50 ml of basic chloroform-methanol solution was added! Extracted with. 40 mf of IN sulfuric acid was added to this and the alkaloid layer was transferred to the sulfuric acid layer. Furthermore, ammonia water 2- and chloroform 40- were added to transfer the alkaloid to the chloroform layer, which was concentrated under reduced pressure and the amount of alkaloid was analyzed using a gas chromatograph. Table 1 shows the production amount of alkaloid in this case. Note that the gas chromatograph analysis was conducted under the following conditions.
カラム: 5ilicone 0V−17(1%) o
nChron+osorb W (Mesh 80
〜10100)3φ×11I+ガラスカラム
キャリャガス二N2
カラム温度 −7200℃
実施例2〜3及び比較例1
表1に示したジアミンのプレトシンまたはジアミノプロ
パンを培地に添加した以外は実施例1と同様にして行っ
た結果(実施例2〜3)及びアミン類を添加しない培地
を用いて実施例1と同様に行った結果(比較例1)を表
1に示した。Column: 5ilicone 0V-17 (1%) o
nChron+osorb W (Mesh 80
~10100) 3φ x 11I + glass column carrier gas 2N2 Column temperature -7200°C Examples 2 to 3 and Comparative Example 1 Same as Example 1 except that the diamine pretocin or diaminopropane shown in Table 1 was added to the medium. Table 1 shows the results obtained in the same manner as in Example 1 (Examples 2 to 3) and the results obtained in the same manner as in Example 1 using a medium to which no amines were added (Comparative Example 1).
実施例4
ズボイシア (Duboisia myoporoid
es R,Br)の葉を10%アンチホルミンで処理し
たのち、ベンジルアデニン10− ’M含むリンスマイ
ヤー・スクーグ(LS)の寒天培地に置床した。1ケ月
後発生した苗条を同じ培地で40日日間化培養して得ら
れるまだ本化していないズボイシア苗条の茎を1〜2c
m程度に切断し、24時間振とう培養したAgroba
cterium rhizogenes HRI−1の
懸濁液(107個/−)に浸漬後、植物ホルモンを含ま
ないLS寒天培地に置床した。3週間後苗条の茎の切断
部位から不定根が発生した。これをアンピシリン0.1
mg /−含むLS液体培地で2日間処理し菌を含まな
い自己増殖性のズボイシア感染不定根を得た。Example 4 Duboisia myoporoid
After treating leaves of es R, Br) with 10% antiformin, they were plated on a Linsmeyer-Skoog (LS) agar medium containing 10-'M benzyladenine. The shoots that emerged after one month were cultured for 40 days in the same medium, and the stems of the Zboisia shoots, which had not yet become fully formed, were 1 to 2 c.
Agroba was cut into pieces of approximately
After immersing in a suspension of cterium rhizogenes HRI-1 (107 cells/-), the cells were placed on an LS agar medium containing no plant hormones. Three weeks later, adventitious roots emerged from the cut site of the shoot stem. Add this to ampicillin 0.1
The roots were treated for 2 days with an LS liquid medium containing 1.0 mg/- to obtain fungus-free, self-propagating adventitious roots infected with Zboisia.
このズボイシア感染不定根をLS液体培地で1年間紙代
培養した。この不定根10mg (乾燥重量)をスペル
ミジンを1mMになるように添加したLS液体培地20
rnlを含む10〇−溶三角フラスコに移植し、2週間
振等培養した。得られた不定根150mg (乾燥重量
)を乾燥し、実施例1と同じ方法で抽出し、アルカロイ
ド量を分析した。この場合のアルカロイドの生産量を表
2に示した。The adventitious roots infected with Zboisia were cultured for one year in a LS liquid medium. 10 mg (dry weight) of these adventitious roots were placed in LS liquid medium 20 containing spermidine added to a concentration of 1 mM.
The cells were transplanted into a 100-ml Erlenmeyer flask containing rnl and cultured with shaking for 2 weeks. 150 mg (dry weight) of the obtained adventitious roots were dried, extracted in the same manner as in Example 1, and analyzed for alkaloid content. Table 2 shows the production amount of alkaloid in this case.
実施例5
アミン類としてプトレシンを添加した培地を用いた以外
は実施例4と同様にして行った結果を表2に示した。Example 5 Table 2 shows the results obtained in the same manner as in Example 4 except that a medium containing putrescine as an amine was used.
比較例2
実施例4においてスペルミジンを添加しながった以外は
該実施例と同様にして行った結果を表2に示した。Comparative Example 2 Table 2 shows the results of the same procedure as in Example 4 except that spermidine was not added.
Claims (1)
アミン類を含有する培地を用いて組織培養してトロパン
系アルカロイドを生産することを特徴とするトロパン系
アルカロイドの生産方法。(1) A method for producing tropane alkaloids, which comprises producing tropane alkaloids by culturing the tissues of plants that produce tropane alkaloids using a medium containing amines.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61230155A JPH0655150B2 (en) | 1986-09-30 | 1986-09-30 | Method for producing tropane alkaloids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61230155A JPH0655150B2 (en) | 1986-09-30 | 1986-09-30 | Method for producing tropane alkaloids |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6384497A true JPS6384497A (en) | 1988-04-15 |
JPH0655150B2 JPH0655150B2 (en) | 1994-07-27 |
Family
ID=16903455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61230155A Expired - Lifetime JPH0655150B2 (en) | 1986-09-30 | 1986-09-30 | Method for producing tropane alkaloids |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0655150B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0198479A (en) * | 1987-04-02 | 1989-04-17 | Mitsui Petrochem Ind Ltd | Method for cultivating protoplast of herbaceous plant |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56121494A (en) * | 1980-02-29 | 1981-09-24 | Eisai Co Ltd | Preparation of tropane alkaloid |
JPS5893453A (en) * | 1981-11-26 | 1983-06-03 | Eisai Co Ltd | Manufacture of alkaloid |
JPS6359897A (en) * | 1986-08-29 | 1988-03-15 | Kokuritsu Eisei Shikenjo | Production of tropane-type alkaloid |
-
1986
- 1986-09-30 JP JP61230155A patent/JPH0655150B2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56121494A (en) * | 1980-02-29 | 1981-09-24 | Eisai Co Ltd | Preparation of tropane alkaloid |
JPS5893453A (en) * | 1981-11-26 | 1983-06-03 | Eisai Co Ltd | Manufacture of alkaloid |
JPS6359897A (en) * | 1986-08-29 | 1988-03-15 | Kokuritsu Eisei Shikenjo | Production of tropane-type alkaloid |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0198479A (en) * | 1987-04-02 | 1989-04-17 | Mitsui Petrochem Ind Ltd | Method for cultivating protoplast of herbaceous plant |
Also Published As
Publication number | Publication date |
---|---|
JPH0655150B2 (en) | 1994-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6384497A (en) | Production of tropan based alkaloid | |
JPH01240194A (en) | Production of tropane-based alkaloid | |
JPH01124383A (en) | Tissue culture of plant | |
JP2502308B2 (en) | Method for culturing protoplasts of herbaceous plant | |
JPH0220291A (en) | Production of tropane-type alkaloid | |
EP0387065A2 (en) | Method for culturing plant tissue, apparatus therefor and method for producing metabolite | |
JPH0648991B2 (en) | Method for producing tropane alkaloid | |
JPH02303431A (en) | Production of tropane-based alkaloid | |
JPS63129989A (en) | Production of tropane alkaloid | |
JPS63167793A (en) | Production of tropane based alkaloid | |
JPH01218595A (en) | Production of tropan-based alkaloid | |
JPH01243995A (en) | Production of tropane based alkaloid | |
JPH02117393A (en) | Production of tropane alkaloid | |
JPS6387991A (en) | Production of tropane-type alkaloid | |
JPS6339595A (en) | Production of alkaloid | |
JPH01300890A (en) | Cell capable of highly producing tropane-based alkaloid and production of said cell | |
CA1134764A (en) | Producing codeine from papaver cell cultures | |
JPS626675A (en) | Method of tissue culture for duboisia leichhardtu f. muell | |
JPS60227673A (en) | Method for selecting cultivated cell of thalictrum thunbergii dc. | |
JPH01273597A (en) | Production of tropan based alkaloid | |
JPH03272681A (en) | Method for culturing tissue of plant, apparatus therefor and production of metabolite thereof | |
JPH0430734A (en) | Formation of adventitious root of thyme | |
JPH02303430A (en) | Method for carrying out tissue culture of adventive root of tropane-based alkaloid producing plant | |
JPS63167790A (en) | Tissure culture | |
JPS60227690A (en) | Tissue culture of "akikaramatsu" (thalicrum hypoleucum) |